A citation-based method for searching scientific literature

Sarah J Tabrizi, Rachael I Scahill, Gail Owen, Alexandra Durr, Blair R Leavitt, Raymund A Roos, Beth Borowsky, Bernhard Landwehrmeyer, Chris Frost, Hans Johnson, David Craufurd, Ralf Reilmann, Julie C Stout, Douglas R Langbehn. Lancet Neurol 2013
Times Cited: 512







List of co-cited articles
735 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.
Sarah J Tabrizi, Douglas R Langbehn, Blair R Leavitt, Raymund Ac Roos, Alexandra Durr, David Craufurd, Christopher Kennard, Stephen L Hicks, Nick C Fox, Rachael I Scahill,[...]. Lancet Neurol 2009
667
36


Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
653
27

Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
557
23

Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
Sarah J Tabrizi, Rachael I Scahill, Alexandra Durr, Raymund Ac Roos, Blair R Leavitt, Rebecca Jones, G Bernhard Landwehrmeyer, Nick C Fox, Hans Johnson, Stephen L Hicks,[...]. Lancet Neurol 2011
396
22

Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Sarah J Tabrizi, Ralf Reilmann, Raymund A C Roos, Alexandra Durr, Blair Leavitt, Gail Owen, Rebecca Jones, Hans Johnson, David Craufurd, Stephen L Hicks,[...]. Lancet Neurol 2012
368
22

CAG repeat number governs the development rate of pathology in Huntington's disease.
J B Penney, J P Vonsattel, M E MacDonald, J F Gusella, R H Myers. Ann Neurol 1997
490
21

Huntington disease: natural history, biomarkers and prospects for therapeutics.
Christopher A Ross, Elizabeth H Aylward, Edward J Wild, Douglas R Langbehn, Jeffrey D Long, John H Warner, Rachael I Scahill, Blair R Leavitt, Julie C Stout, Jane S Paulsen,[...]. Nat Rev Neurol 2014
564
19

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.
D R Langbehn, R R Brinkman, D Falush, J S Paulsen, M R Hayden. Clin Genet 2004
545
17

Data Analytics from Enroll-HD, a Global Clinical Research Platform for Huntington's Disease.
Georg B Landwehrmeyer, Cheryl J Fitzer-Attas, Joseph D Giuliano, Nilza Gonçalves, Karen E Anderson, Francisco Cardoso, Joaquim J Ferreira, Tiago A Mestre, Julie C Stout, Cristina Sampaio. Mov Disord Clin Pract 2016
97
17

Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
Rachael I Scahill, Paul Zeun, Katherine Osborne-Crowley, Eileanoir B Johnson, Sarah Gregory, Christopher Parker, Jessica Lowe, Akshay Nair, Claire O'Callaghan, Christelle Langley,[...]. Lancet Neurol 2020
55
30

Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.
Jane S Paulsen, Jeffrey D Long, Hans J Johnson, Elizabeth H Aylward, Christopher A Ross, Janet K Williams, Martha A Nance, Cheryl J Erwin, Holly J Westervelt, Deborah L Harrington,[...]. Front Aging Neurosci 2014
139
15

Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.
Jane S Paulsen, Jeffrey D Long, Christopher A Ross, Deborah L Harrington, Cheryl J Erwin, Janet K Williams, Holly James Westervelt, Hans J Johnson, Elizabeth H Aylward, Ying Zhang,[...]. Lancet Neurol 2014
150
15

Neurocognitive signs in prodromal Huntington disease.
Julie C Stout, Jane S Paulsen, Sarah Queller, Andrea C Solomon, Kathryn B Whitlock, J Colin Campbell, Noelle Carlozzi, Kevin Duff, Leigh J Beglinger, Douglas R Langbehn,[...]. Neuropsychology 2011
257
14

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
Lauren M Byrne, Filipe B Rodrigues, Kaj Blennow, Alexandra Durr, Blair R Leavitt, Raymund A C Roos, Rachael I Scahill, Sarah J Tabrizi, Henrik Zetterberg, Douglas Langbehn,[...]. Lancet Neurol 2017
174
14

Huntington's disease: a clinical review.
P McColgan, S J Tabrizi. Eur J Neurol 2018
351
13

Behavioral changes in Huntington Disease.
D Craufurd, J C Thompson, J S Snowden. Neuropsychiatry Neuropsychol Behav Neurol 2001
284
12

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
12

Huntington's disease: a clinical review.
Raymund A C Roos. Orphanet J Rare Dis 2010
463
12

Motor, cognitive, and functional declines contribute to a single progressive factor in early HD.
Scott A Schobel, Giuseppe Palermo, Peggy Auinger, Jeffrey D Long, Shiyang Ma, Omar S Khwaja, Dylan Trundell, Merit Cudkowicz, Steven Hersch, Cristina Sampaio,[...]. Neurology 2017
57
21

Association of CAG Repeats With Long-term Progression in Huntington Disease.
Douglas R Langbehn, Julie C Stout, Sarah Gregory, James A Mills, Alexandra Durr, Blair R Leavitt, Raymund A C Roos, Jeffrey D Long, Gail Owen, Hans J Johnson,[...]. JAMA Neurol 2019
21
57

Behavioural abnormalities contribute to functional decline in Huntington's disease.
J M Hamilton, D P Salmon, J Corey-Bloom, A Gamst, J S Paulsen, S Jerkins, M W Jacobson, G Peavy. J Neurol Neurosurg Psychiatry 2003
123
11

Longitudinal change in regional brain volumes in prodromal Huntington disease.
Elizabeth H Aylward, Peggy C Nopoulos, Christopher A Ross, Douglas R Langbehn, Ronald K Pierson, James A Mills, Hans J Johnson, Vincent A Magnotta, Andrew R Juhl, Jane S Paulsen. J Neurol Neurosurg Psychiatry 2011
175
11

Huntington's disease.
Francis O Walker. Lancet 2007
11

Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study.
Stefan Klöppel, Sarah Gregory, Elisa Scheller, Lora Minkova, Adeel Razi, Alexandra Durr, Raymund A C Roos, Blair R Leavitt, Marina Papoutsi, G Bernhard Landwehrmeyer,[...]. EBioMedicine 2015
83
13


Targeting Huntingtin Expression in Patients with Huntington's Disease.
Sarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, Edward J Wild, Carsten Saft, Roger A Barker, Nick F Blair, David Craufurd, Josef Priller, Hugh Rickards,[...]. N Engl J Med 2019
313
11

CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.
Douglas R Langbehn, Michael R Hayden, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2010
220
10


Preparing for preventive clinical trials: the Predict-HD study.
Jane S Paulsen, Michael Hayden, Julie C Stout, Douglas R Langbehn, Elizabeth Aylward, Christopher A Ross, Mark Guttman, Martha Nance, Karl Kieburtz, David Oakes,[...]. Arch Neurol 2006
237
10


Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease.
Jennifer C Thompson, Jenny Harris, Andrea C Sollom, Cheryl L Stopford, Elizabeth Howard, Julie S Snowden, David Craufurd. J Neuropsychiatry Clin Neurosci 2012
114
9

Huntington's disease: from molecular pathogenesis to clinical treatment.
Christopher A Ross, Sarah J Tabrizi. Lancet Neurol 2011
964
9

Indexing disease progression at study entry with individuals at-risk for Huntington disease.
Ying Zhang, Jeffrey D Long, James A Mills, John H Warner, Wenjing Lu, Jane S Paulsen. Am J Med Genet B Neuropsychiatr Genet 2011
152
9

Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease.
Julie C Stout, Rebecca Jones, Izelle Labuschagne, Alison M O'Regan, Miranda J Say, Eve M Dumas, Sarah Queller, Damian Justo, Rachelle Dar Santos, Allison Coleman,[...]. J Neurol Neurosurg Psychiatry 2012
94
9

Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.
Saul Martinez-Horta, Jesus Perez-Perez, Erik van Duijn, Ramon Fernandez-Bobadilla, Mar Carceller, Javier Pagonabarraga, Berta Pascual-Sedano, Antonia Campolongo, Jesus Ruiz-Idiago, Frederic Sampedro,[...]. Parkinsonism Relat Disord 2016
85
10

Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories.
Christopher A Ross, Ralf Reilmann, Francisco Cardoso, Elizabeth A McCusker, Claudia M Testa, Julie C Stout, Blair R Leavitt, Zhong Pei, Bernhard Landwehrmeyer, Asuncion Martinez,[...]. Mov Disord Clin Pract 2019
28
32

Earliest functional declines in Huntington disease.
Leigh J Beglinger, Justin J F O'Rourke, Chiachi Wang, Douglas R Langbehn, Kevin Duff, Jane S Paulsen. Psychiatry Res 2010
89
8

Health-related quality of life in Huntington's disease: Which factors matter most?
Aileen K Ho, Abigail S Gilbert, Sarah L Mason, Anna O Goodman, Roger A Barker. Mov Disord 2009
96
8

Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.
Kevin Duff, Jane S Paulsen, Leigh J Beglinger, Douglas R Langbehn, Julie C Stout. Biol Psychiatry 2007
273
8

Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
Erik van Duijn, David Craufurd, Anna A M Hubers, Erik J Giltay, Raphael Bonelli, Hugh Rickards, Karen E Anderson, Marleen R van Walsem, Rose C van der Mast, Michael Orth,[...]. J Neurol Neurosurg Psychiatry 2014
138
8

The Neuropsychology of Huntington's Disease.
Julie S Snowden. Arch Clin Neuropsychol 2017
54
14

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
Ziad S Nasreddine, Natalie A Phillips, Valérie Bédirian, Simon Charbonneau, Victor Whitehead, Isabelle Collin, Jeffrey L Cummings, Howard Chertkow. J Am Geriatr Soc 2005
8

Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
Govinda R Poudel, Julie C Stout, Juan F Domínguez D, Andrew Churchyard, Phyllis Chua, Gary F Egan, Nellie Georgiou-Karistianis. Neurobiol Dis 2015
65
12

Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
Juan F Domínguez D, Gary F Egan, Marcus A Gray, Govinda R Poudel, Andrew Churchyard, Phyllis Chua, Julie C Stout, Nellie Georgiou-Karistianis. PLoS One 2013
61
13

Social cognition in Huntington's disease: A meta-analysis.
Emre Bora, Dennis Velakoulis, Mark Walterfang. Behav Brain Res 2016
58
13

Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.
Lauren M Byrne, Filipe B Rodrigues, Eileanor B Johnson, Peter A Wijeratne, Enrico De Vita, Daniel C Alexander, Giuseppe Palermo, Christian Czech, Scott Schobel, Rachael I Scahill,[...]. Sci Transl Med 2018
68
11

Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease.
Filipe B Rodrigues, Lauren M Byrne, Rosanna Tortelli, Eileanoir B Johnson, Peter A Wijeratne, Marzena Arridge, Enrico De Vita, Naghmeh Ghazaleh, Richard Houghton, Hannah Furby,[...]. Sci Transl Med 2020
25
32

Diagnostic criteria for Huntington's disease based on natural history.
Ralf Reilmann, Blair R Leavitt, Christopher A Ross. Mov Disord 2014
108
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.